α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model-Reference-Cited by-同舟云学术

α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model

Published:2011-11 Issue:51 Volume:29 Page:9529-9537
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Jenikova Gabriela,Hruz Petr,Andersson Mattias K.,Tejman-Yarden Noa,Ferreira Patricia C.D.,Andersen Yolanda S.,Davids Barbara J.,Gillin Frances D.,Svärd Staffan G.,Curtiss Roy,Eckmann Lars

Funder

NIH

Swedish Research Council

Sweden-America Foundation

FAPESP (São Paulo Reasearch Foundation)

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference60 articles.

1. Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt;Karanis;J Water Health,2007

2. Successful experimental infections of a human volunteer and Mongolian gerbils with Giardia of animal origin;Majewska;Trans R Soc Trop Med Hyg,1994

3. Experimental human infections with Giardia lamblia;Nash;J Infect Dis,1987

4. Giardia—diagnosis clinical course and epidemiology. A review;Flanagan;Epidemiol Infect,1992

5. Pathophysiology of enteric infections with Giardia duodenalius;Buret;Parasite,2008

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucosal vaccination in a murine gnotobiotic model of Giardia lamblia infection;Infection and Immunity;2024-06-11

2. Giardiasis;The Diagnosis and Treatment of Protozoan Diseases;2024

3. The NLRP3 inflammasome recognizes alpha-2 and alpha-7.3 giardins and decreases the pathogenicity of Giardia duodenalis in mice;Parasites & Vectors;2023-03-03

4. A core UPS molecular complement implicates unique endocytic compartments at the parasite–host interface in Giardia lamblia;Virulence;2023-02-13

5. Drugs for giardiasis, trichomoniasis, and leishmaniasis;Medicinal Chemistry of Chemotherapeutic Agents;2023